S L R Pierie, M E N Pierie, N J G M Veeger, O Schouten
{"title":"支腔或开孔腔内动脉瘤修复术治疗1A型腔内漏围手术期及中期结果","authors":"S L R Pierie, M E N Pierie, N J G M Veeger, O Schouten","doi":"10.1016/j.avsg.2025.05.019","DOIUrl":null,"url":null,"abstract":"<p><strong>Introduction and aim: </strong>The treatment of a failing Endovascular Aneurysm Repair (EVAR) due to loss of proximal sealing is challenging. Branched or Fenestrated Endovascular Aneurysm Repair (B/FEVAR) offer a promising endovascular solution. This study evaluates B/FEVAR outcomes for managing type 1A endoleak after EVAR.</p><p><strong>Patient and methods: </strong>All consecutive patients who underwent B/FEVAR surgery to treat a type 1A endoleak after EVAR at a large teaching hospital between 2019 and 2024 were included in this study. Outcomes analyzed included aneurysm-related mortality, overall survival, technical success, endoleaks, aneurysm sac dynamics, re-interventions, target vessel patency, target vessel instability, and other complications. Regular follow-up after B/FEVAR surgery included imaging at 1, 6, and 12 months and annually thereafter.</p><p><strong>Results: </strong>Among 24 patients (96% males, median age 73 (range: 66-80)), the median interval between EVAR and B/FEVAR was 6.6 years (range: 2-11). No aneurysm-related mortality was observed during follow-up. Median follow-up was 20 months (range: 3-67) and overall survival was 95%. The primary technical success rate was 88%, and the assisted primary technical success rate was 92%. Type 2 endoleaks were observed in 33% of patients, while type 3 endoleaks occurred in 13% of patients. Aneurysm sac regression during follow-up was reported in 17%, stabilization in 71% and expansion in 13% of patients. Re-interventions were required in 25% of patients. Primary target vessel patency and assisted primary target vessel patency were 95% and 97%. Target vessel instability was 8%.</p><p><strong>Conclusion: </strong>B/FEVAR appears to be a safe, and effective option for managing type 1A endoleaks after prior EVAR based on midterm outcomes.</p>","PeriodicalId":8061,"journal":{"name":"Annals of vascular surgery","volume":" ","pages":""},"PeriodicalIF":1.4000,"publicationDate":"2025-05-23","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Perioperative and midterm outcomes of Branched or Fenestrated Endovascular Aneurysm Repair for type 1A endoleak after Endovascular Aneurysm Repair.\",\"authors\":\"S L R Pierie, M E N Pierie, N J G M Veeger, O Schouten\",\"doi\":\"10.1016/j.avsg.2025.05.019\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><strong>Introduction and aim: </strong>The treatment of a failing Endovascular Aneurysm Repair (EVAR) due to loss of proximal sealing is challenging. Branched or Fenestrated Endovascular Aneurysm Repair (B/FEVAR) offer a promising endovascular solution. This study evaluates B/FEVAR outcomes for managing type 1A endoleak after EVAR.</p><p><strong>Patient and methods: </strong>All consecutive patients who underwent B/FEVAR surgery to treat a type 1A endoleak after EVAR at a large teaching hospital between 2019 and 2024 were included in this study. Outcomes analyzed included aneurysm-related mortality, overall survival, technical success, endoleaks, aneurysm sac dynamics, re-interventions, target vessel patency, target vessel instability, and other complications. Regular follow-up after B/FEVAR surgery included imaging at 1, 6, and 12 months and annually thereafter.</p><p><strong>Results: </strong>Among 24 patients (96% males, median age 73 (range: 66-80)), the median interval between EVAR and B/FEVAR was 6.6 years (range: 2-11). No aneurysm-related mortality was observed during follow-up. Median follow-up was 20 months (range: 3-67) and overall survival was 95%. The primary technical success rate was 88%, and the assisted primary technical success rate was 92%. Type 2 endoleaks were observed in 33% of patients, while type 3 endoleaks occurred in 13% of patients. Aneurysm sac regression during follow-up was reported in 17%, stabilization in 71% and expansion in 13% of patients. Re-interventions were required in 25% of patients. Primary target vessel patency and assisted primary target vessel patency were 95% and 97%. Target vessel instability was 8%.</p><p><strong>Conclusion: </strong>B/FEVAR appears to be a safe, and effective option for managing type 1A endoleaks after prior EVAR based on midterm outcomes.</p>\",\"PeriodicalId\":8061,\"journal\":{\"name\":\"Annals of vascular surgery\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":1.4000,\"publicationDate\":\"2025-05-23\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Annals of vascular surgery\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1016/j.avsg.2025.05.019\",\"RegionNum\":4,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"PERIPHERAL VASCULAR DISEASE\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Annals of vascular surgery","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1016/j.avsg.2025.05.019","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"PERIPHERAL VASCULAR DISEASE","Score":null,"Total":0}
Perioperative and midterm outcomes of Branched or Fenestrated Endovascular Aneurysm Repair for type 1A endoleak after Endovascular Aneurysm Repair.
Introduction and aim: The treatment of a failing Endovascular Aneurysm Repair (EVAR) due to loss of proximal sealing is challenging. Branched or Fenestrated Endovascular Aneurysm Repair (B/FEVAR) offer a promising endovascular solution. This study evaluates B/FEVAR outcomes for managing type 1A endoleak after EVAR.
Patient and methods: All consecutive patients who underwent B/FEVAR surgery to treat a type 1A endoleak after EVAR at a large teaching hospital between 2019 and 2024 were included in this study. Outcomes analyzed included aneurysm-related mortality, overall survival, technical success, endoleaks, aneurysm sac dynamics, re-interventions, target vessel patency, target vessel instability, and other complications. Regular follow-up after B/FEVAR surgery included imaging at 1, 6, and 12 months and annually thereafter.
Results: Among 24 patients (96% males, median age 73 (range: 66-80)), the median interval between EVAR and B/FEVAR was 6.6 years (range: 2-11). No aneurysm-related mortality was observed during follow-up. Median follow-up was 20 months (range: 3-67) and overall survival was 95%. The primary technical success rate was 88%, and the assisted primary technical success rate was 92%. Type 2 endoleaks were observed in 33% of patients, while type 3 endoleaks occurred in 13% of patients. Aneurysm sac regression during follow-up was reported in 17%, stabilization in 71% and expansion in 13% of patients. Re-interventions were required in 25% of patients. Primary target vessel patency and assisted primary target vessel patency were 95% and 97%. Target vessel instability was 8%.
Conclusion: B/FEVAR appears to be a safe, and effective option for managing type 1A endoleaks after prior EVAR based on midterm outcomes.
期刊介绍:
Annals of Vascular Surgery, published eight times a year, invites original manuscripts reporting clinical and experimental work in vascular surgery for peer review. Articles may be submitted for the following sections of the journal:
Clinical Research (reports of clinical series, new drug or medical device trials)
Basic Science Research (new investigations, experimental work)
Case Reports (reports on a limited series of patients)
General Reviews (scholarly review of the existing literature on a relevant topic)
Developments in Endovascular and Endoscopic Surgery
Selected Techniques (technical maneuvers)
Historical Notes (interesting vignettes from the early days of vascular surgery)
Editorials/Correspondence